The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, randomized, double-blinded, placebo-controlled study of simtuzumab or placebo in combination with FOLFIRI for the second line treatment of metastatic KRAS mutant colorectal adenocarcinoma.
 
J. Randolph Hecht
No Relationships to Disclose
 
Johanna C. Bendell
No Relationships to Disclose
 
Dmitry Vyushkov
No Relationships to Disclose
 
Katia Bencardino
No Relationships to Disclose
 
Udit N. Verma
No Relationships to Disclose
 
Yingsi Yang
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Dung Luong Thai
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences